Natural products which interact with tubulin in the vinca domain: Maytansine, rhizoxin, phomopsin a, dolastatins 10 and 15 and halichondrin B

Pharmacology and Therapeutics

Volumn 55, Issue 1, 1992, Pages 31-51

  Hamel, Ernest ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANSAMITOCIN; DOLASTATIN; HALICHONDRIN B; HALISTATIN; HOMOHALICHONDRIN B; MAYTANSINE; NORHALICHODRIN B; PHOMOPSIN A; RHIZOXIN; TRIPEPTIDE A; TUBULIN; UNCLASSIFIED DRUG; VINCA ALKALOID;

ANIMAL CELL; DRUG PROTEIN BINDING; DRUG STRUCTURE; LIGAND BINDING; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION;

ANIMAL; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ETHERS, CYCLIC; LACTONES; MAYTANSINE; MYCOTOXINS; OLIGOPEPTIDES; TUBULIN; VINCA ALKALOIDS;

EID: 0027093080     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/0163-7258(92)90028-X     Document Type: Review

References (102)

1. Total synthesis of halichondrin B and norhalichondrin B
2. Characterization of post-translational modifications in neuron-specific class III ß-tubulin by mass spectrometry
3. Role of GTP in the assembly of microtubules
4. Incorporation of l-tyrosine, l-phenylalanine and l-3,4-dihydroxyphenylalanine as single units into rat brain tubulin
5. Isolation, chemical characterization and structure of ansamitocin, a new antitumor ansamycin antibiotic
6. Binding of dolastatin 10 to tubulin at a distinct site for peptide antimotic agents near the exhangeable nucleotide and vinca alkaloid sites
7. Dolastatin 10, a powerful cytostatic peptide derived from a marine animal: inhibition of tubulin polymerization mediated through the vinca alkaloid binding domain
8. Structure-activity studies with chiral isomers and with segments of the antimitotic marine peptide dolastatin 10
9. Halichondrin B and homohalichondrin B, marine natural products binding in the vinca domain of tubulin: discovery of tubulin-based mechanism of action by analysis of differential cytotoxicity data
10. Dolastatin 15, a potent antimotic depsipeptide derived from Dolabella auricularia: interaction with tubulin and effects on cellular microtubules
11. Derivatives of 5,6-diphenylpyridazin-3-one: synthetic antimitotic agents which interact with plant and mammalian tubulin at a new drug-binding site
12. Maytansine binding to the vinblastine sites on tubulin
13. Phase I and pharmacokinetic study of rhizoxin
14. Crystal and molecular structure and absolute configuration of maytansine (3-bromopropyl) ether
15. Results of a phase II study of maytansine in patients with breast carcinoma and melanoma
16. Stoichiometry for guanine nucleotide binding to tubulin under polymerizing and nonpolymerizing conditions
17. Immunoconjugates containing novel maytasinoids: promising anticancer drugs
18. Isolation of toxic metabolites of Phomopsis leptostromiformis responsible for lupinosis
19. Structure elucidation of phomopsin A a novel cyclic hexapeptide mycotoxin produced by Phomopsis leptostromiformis
20. Guanosinetriphosphatase activity of tubulin associated with microtubule assembly
21. Post-translational glutamylation of α-tubulin
22. Rat brain microtubule protein: purification and determination of covalently bound phosphate and carbohydrate
23. 2 on the interaction of maytansine with tubulin: inhibitory effect of maytansine on vinblastine-induced aggregation of tubulin
24. Interactions of a photoaffinity analog of GTP with the proteins of microtubules
25. Efficient stereoselective synthesis of dolastatin 10, an antineoplastic peptide from a sea hare
26. Interactions of tubulin with small ligands
27. Ansamitocin, a group of novel maytansinoid antibiotics with antitumor properties from Nocardia
28. Interactions of the Catharanthus (Vinca)_alkaloids with tubulin and microtubules
29. Halichondrins—antitumor polyether macrolides from a marine sponge
30. Maytansine inhibits nucleotide binding at the exchangeable site of tubulin
31. Studies on rice seedling blight. I. Growth injury caused by Rhizopus sp. under high temperature
32. Studies on macrocyclic lactone antibiotics. VII. Structure of a phytotoxin ‘rhizosin’ produced by Rhizopus chinensis
33. Studies on macrocyclic lactone antibiotics. IX. Novel macrolides from the fungus Rhizopus chinensis: precursors of rhizoxin
34. Studies on macrocyclic lactone antibiotics. VIII. Absolute structures of rhizoxin and a related compound
35. Studies on macrocyclic lactone antibiotics. XIII. Anti-tubulin activity and cytotoxicity of rhizoxin derivatives: synthesis of a photoaffinity derivative
36. Biosynthesis of the antimitotic antitumor antibiotic rhizoxin by Rhizopus chinensis origins of the carbon atoms
37. Nucleotides bound to brain tubulin and reconstituted microtubules
38. Complete amino acid sequence of ß-tubulin from porcine brain
39. Maytansine, a novel antileukemic ansa macrolide from Maytenus ovatus
40. Novel maytansinoids. Structural interrelations and requirements for antileukemic activity
41. Novel maytansinoids. Naturally occuring and synthetic antileukemic esters of maytansinol
42. The maytansinoids. Isolation, structural elucidation and chemical interrelation of novel ansa macrolides
43. Structural requirements for antileukemic activity among the naturally occuring and semisynthetic maytansinoids
44. Interaction of phomopsin A and related compounds with purified sheep brain tubulin
45. Studies on the binding of GTP to the microtubule protein
46. Interaction of phomopsin A with porcine brain tubulin inhibition of tubulin polymerization and binding at a rhizoxin binding site
47. Effects of inhibitors of tubulin polymerization on GTP hydrolysis
48. Interrelationships of tubulin-GDP and tubulin-GTP in microtubule assembly
49. Structural differences between brain ß 1- and ß 2-tubulins: implications for microtubule assembly and colchicine binding
50. 1-tubulin that can be cross-linked after removal of exchangeable GTP
51. Contrasting effects of maytansine and vinblastine on the alkylation of tubulin sulfhydryls
52. Interaction of tubulin with drugs and alkylating agents. 2. Effects of colchicine, podophyllotoxin and vinblastine on the alkylation of tubulin
53. Tubulin sulfhydryl groups as probes and targets for antimitotic and antimicrotubule agents
54. 2-Tubulin, a form of chordate brain tubulin with lesser reactivity toward an assembly-inhibiting sulfhydryl-directed cross-linking reagent
55. The interaction of phomopsin A with bovine brain tubulin
56. Effect of phomopsin A on the alkylation of tubulin
57. The interaction of dolastatin 10 and halichondrin B with bovine brain tubulin
58. Interaction of dolastatin 10 with bovine brain tubulin
59. The X-ray structure of phomopsin A, a hexapeptide mycotoxin
60. Binding of maytansine to rat brain tubulin
61. The acetylation of alpha tubulin and its relationship to the assembly and disassembly of microtubules
62. Direct photoaffinity labeling of tubulin with guanosine 5′-triphosphate
63. Effects of new antimitotic antibiotics, ansamitocins, on the growth of murine in vivo and on the assembly of microtubules in vitro
64. Alteration in cell division, morphology and motility induced by the toxic principle of lupinosis
65. The isolation and structure of a remarkable marine animal antineoplastic constituent: dolastatin 10
66. The structure and synthesis of dolastatin 3
67. Isolation and structure of the cytostatic linear depsipeptide dolastatin 15
68. Isolation and structure of the cytostatic depsipetide dolastatin 13 from the sea hare Dolabella auricularia
69. Isolation and structure of the cell growth inhibitory depsipeptides dolastatins 11 and 12
70. The absolute configuration and synthesis of natural (−)-dolastatin 10
71. Antineoplastic agents 190 Isolation and structure of the cyclodepsipeptide dolastatin 14
72. Isolation and structure of the cell growth inhibitory constituents from the Western Pacific marine sponge Axinella sp
73. Antineoplastic agents. 220. Synthesis of natural (−)-dolastatin 15
74. Complete amino acid sequence of α-tubulin from porcine brain
75. Bis(8-anilinonaphthalene-1-sulfonate) as a probe for tubulin decay
76. Antimitotic activity of the potent tumor inhibitor maytansine
77. 1-tubulin
78. Phase II study of maytansine in patients with advanced lymphomas: an Eastern Cooperative Oncology Group pilot study
79. The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics
80. Photoaffinity labeling of tubulin subunits with a photoactive analog of vinblastine
81. Fluorescent and photoaffinity labeling derivatives of rhizoxin
82. Maytansine-resistant mutants of Chinese hamster ovary cells with an alteration in α-tubulin
83. Promotion of microtubule assembly in vitro by taxol
84. Turnover of tubulin and the N site GTP in Chinese hamster ovary cells
85. Antimicrotubule effects of estramustine, an antiprostatic tumor drug
86. Interaction of rhizoxin with bovine brain tubulin
87. Studies on macrocyclic lactone antibiotics. XI. Antimitotic and antitubulin activity of new antitumor antibiotics, rhizoxin and its homologues
88. Rhizoxin binding to tubulin at the maytansine-binding site
89. Rhizoxin Resistant mutants with an altered ß-tubulin gene in Aspergillus nidulans
90. Molecular basis for determining the sensitivity of eucaryotes to the antimitotic drug rhizoxin
91. Physical and spectroscopic methods for the evaluation of the interactions of antimitotic agents with tubulin
92. Phomopsin A, the causative agent of lupinosis, interacts with microtubules in vivo and in vitro
93. Rhizoxin, a macrocyclic lactone antibiotic, as a new antitumor agent against human and murine tumor cells and their vincristine-resistant sublines
94. Norhalinchondrin A: an antitumor polyether macrolide from a marine sponge
95. Interaction of estramustine phosphate with microtubule-associated proteins
96. Plant antitumor agents: colubrinol acetate and colubrinol antileukaemic ansa macrolides from Caulubrina texensis
97. The colchicine-binding protein of mammalian brain and its relation ot microtubules
98. Tubulin-nucleotide interactions during the polymerization and depolimerization of microtubules
99. Initial studies on the cytotoxic action of maytansine, a novel ansa macrolide
100. Initial studies on maytansine-induced metaphase arrest in L1210 murine leukemia cells
101. Binding of maytansinoids to tubulin